ID 7.6.53300 Cardior Pharmaceuticals - RNA based therapeutics targeting heart failure and cardiac regeneration.

RNA based therapeutics targeting heart failure and cardiac repair

Cardior develops RNA based therapies for heart failure and cardiac repair. Programs are built on biomarker platforms and preclinical models that inform clinical translation. Partnerships with leading centers help progress candidates efficiently. The company aims to expand treatment options for cardiovascular disease with precise, well characterised modalities.

Organization

Listed as: Brand page

Brand:

Cardior Pharmaceuticals

Country:

DE

Official page
  • Category: 7. Healthcare & Life Sciences
  • Subcategory: 7.6 Biotech
  • Technology: RNA therapeutics. Biomarker platforms. Preclinical models. Clinical translation.
  • Release Date:
  • Canonical Url: